首页> 美国卫生研究院文献>other >Clinical outcome comparison of polymethylmethacrylate bone cement with and without mineralized collagen modification for osteoporotic vertebral compression fractures
【2h】

Clinical outcome comparison of polymethylmethacrylate bone cement with and without mineralized collagen modification for osteoporotic vertebral compression fractures

机译:有无矿化胶原蛋白改性的聚甲基丙烯酸甲酯骨水泥治疗骨质疏松性椎体压缩性骨折的临床效果比较

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A retrospective study of consecutive patients.The purpose of this study was to compare the clinical effect of biomimetic mineralized collagen (MC) modified polymethylmethacrylate (PMMA) bone cement and traditional PMMA bone cement for the treatment of osteoporotic vertebral compression fractures (OVCF).New fracture on adjacent level is the major postoperative complication of percutaneous vertebroplasty (PVP). The clinical incidence was 12.4% to 27.7%. The increased stiffness of the treated vertebral body caused by filling bone cement is considered as one of the main reasons.A total of 30 patients treated with traditional PMMA bone cement from June 2013 to March 2016 were selected as the traditional group, while 50 patients treated with MC modified PMMA bone cement from July 2014 to March 2016 were selected as the modified group. The 2 groups were compared by injection time of the bone cements, postoperative pain relief effects, vertebral height restoration, CT value changes of the treated vertebral bodies, and postoperative complications in the clinical observations.The surgeries were successfully completed in both groups. In the treatment of OVCF, the MC modified bone cement was able to achieve the same pain relief and vertebral height restoration effects compared to traditional bone cement during the follow-ups, although the injection time of the cement was prolonged in the operation. MC modified bone cement significantly reduced the incidence of postoperative adjacent vertebral fracture from 13.3% to 2%, and significantly increased bone density of the treated vertebral bodies.The MC modified PMMA bone cement showed good clinical outcomes and better mechanical properties than the traditional bone cements.
机译:连续患者的一项回顾性研究。本研究的目的是比较仿生矿化胶原蛋白(MC)改性的聚甲基丙烯酸甲酯(PMMA)骨水泥和传统PMMA骨水泥治疗骨质疏松性椎体压缩性骨折(OVCF)的临床效果。邻近水平的骨折是经皮椎体成形术(PVP)的主要术后并发症。临床发病率为12.4%至27.7%。填充骨水泥引起的椎体刚度增加被认为是主要原因之一.2013年6月至2016年3月,共有30例接受传统PMMA骨水泥治疗的患者被选为传统患者,其中50例接受了治疗。 2014年7月至2016年3月采用MC改性PMMA骨水泥作为改性组。比较两组患者的骨水泥注射时间,术后止痛效果,椎体高度的恢复,所治疗椎体CT值的变化以及术后并发症的临床观察。两组均顺利完成手术。在OVCF的治疗中,尽管在手术过程中延长了水泥的注射时间,但在随访过程中,MC改性的骨水泥与传统的骨水泥相比能够达到相同的止痛和椎高恢复效果。 MC改性骨水泥可将术后邻近椎体骨折的发生率从13.3%降低至2%,并显着提高治疗椎体的骨密度.MC改性PMMA骨水泥与传统骨水泥相比具有良好的临床疗效和更好的力学性能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号